• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    9/15/23 11:52:24 AM ET
    $PLNT
    $PLRX
    $PMF
    $PML
    Hotels/Resorts
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $PLNT alert in real time by email

     

    Friday's session saw 169 companies set new 52-week lows.

    Points of Interest From Today's 52-Week Lows:

    • Bristol-Myers Squibb (NYSE:BMY) was the largest firm by market cap to set a new 52-week low.
    • Blue Star Foods (NASDAQ:BSFC) was the smallest company in terms of market cap to set a new 52-week low.
    • PTC Therapeutics (NASDAQ:PTCT)'s stock fell the most, as it traded down 31.29% to reach a new 52-week low.
    • Prelude Therapeutics (NASDAQ:PRLD)'s stock bounced back the most, actually rising 0.0% after reaching its new 52-week low.

    On Friday, the following stocks set new 52-week lows:

    • Bristol-Myers Squibb (NYSE:BMY) stock dropped to a yearly low on Friday of $58.92. Shares traded down 0.87%.
    • Realty Income (NYSE:O) shares reached a new 52-week low of $54.29 on Friday morning, moving down 1.42%.
    • Illumina (NASDAQ:ILMN) stock hit a yearly low of $145.14. The stock was down 3.41% for the day.
    • ResMed (NYSE:RMD) stock hit $145.74 on Friday morning, setting a new 52-week low for a change of down 0.98%.
    • Royalty Pharma (NASDAQ:RPRX) shares made a new 52-week low of $28.21 on Friday. The stock was down 1.67% for the day.
    • Insulet (NASDAQ:PODD) stock hit $166.03 on Friday morning, setting a new 52-week low for a change of down 3.92%.
    • Chewy (NYSE:CHWY) stock set a new 52-week low of $20.48 on Friday, moving down 2.75%.
    • TKO Group Holdings (NYSE:TKO) shares fell to $99.24 on Friday, setting a new 52-week low with a shift of down 1.27%.
    • SolarEdge Technologies (NASDAQ:SEDG) stock hit a new 52-week low of $141.67. The stock was down 1.29% on the session.
    • Liberty SiriusXM Gr (NASDAQ:LSXMB) shares reached a new 52-week low of $22.19 on Friday morning, moving down 3.38%.
    • Agree Realty (NYSE:ADC) shares set a new 52-week low of $59.51. The stock traded down 0.9%.
    • Envista Holdings (NYSE:NVST) shares made a new 52-week low of $28.74 on Friday. The stock was down 0.62% for the day.
    • Planet Fitness (NYSE:PLNT) stock dropped to a yearly low on Friday of $50.21. Shares traded down 15.17%.
    • Cava Group (NYSE:CAVA) stock broke to a new 52-week low of $34.42 on Friday. Shares of the company traded down 3.66%.
    • Medical Properties Trust (NYSE:MPW) stock achieved a new 52-week low on Friday morning, hitting $6.28 and moving down 3.72%.
    • PNM Resources (NYSE:PNM) stock broke to a new 52-week low of $43.64 on Friday. Shares of the company traded down 0.22%.
    • Savers Value Village (NYSE:SVV) shares fell to $19.61 on Friday, setting a new 52-week low with a shift of down 2.02%.
    • Physicians Realty Trust (NYSE:DOC) shares hit a yearly low of $12.94. The stock was down 3.03% on the session.
    • Macy's (NYSE:M) stock hit $11.15 on Friday morning, setting a new 52-week low for a change of down 1.54%.
    • Tower Semiconductor (NASDAQ:TSEM) stock dropped to a yearly low on Friday of $27.23. Shares traded down 2.22%.
    • Galapagos (NASDAQ:GLPG) stock dropped to a yearly low on Friday of $36.00. Shares traded down 0.11%.
    • PTC Therapeutics (NASDAQ:PTCT) shares set a new yearly low of $24.43 this morning. The stock was down 31.29% on the session.
    • Grupo Televisa (NYSE:TV) stock set a new 52-week low of $3.41 on Friday, moving down 2.01%.
    • Mister Car Wash (NYSE:MCW) shares hit a yearly low of $6.04. The stock was down 1.61% on the session.
    • Peloton Interactive (NASDAQ:PTON) shares hit a yearly low of $4.96. The stock was down 2.43% on the session.
    • Spirit AeroSystems Hldgs (NYSE:SPR) shares were up 1.28% for the day, having made a 52-week low of $16.28.
    • Silicon Motion Technology (NASDAQ:SIMO) shares set a new 52-week low of $50.51. The stock traded down 1.35%.
    • Supernus Pharmaceuticals (NASDAQ:SUPN) shares set a new 52-week low of $28.77. The stock traded down 1.13%.
    • ZIM Integrated Shipping (NYSE:ZIM) shares set a new yearly low of $11.15 this morning. The stock was up 0.45% on the session.
    • Amylyx Pharma (NASDAQ:AMLX) shares set a new yearly low of $19.36 this morning. The stock was up 0.25% on the session.
    • Petco Health and Wellness (NASDAQ:WOOF) stock drifted down 3.78% on Friday morning to hit a new 52-week low of $4.44.
    • Syndax Pharmaceuticals (NASDAQ:SNDX) stock hit a yearly low of $16.76. The stock was down 0.21% for the day.
    • Netstreit (NYSE:NTST) stock broke to a new 52-week low of $16.62 on Friday. Shares of the company traded up 0.3%.
    • Phreesia (NYSE:PHR) stock hit a new 52-week low of $19.52. The stock was down 1.44% on the session.
    • Pliant Therapeutics (NASDAQ:PLRX) shares reached a new 52-week low of $15.82 on Friday morning, moving down 0.56%.
    • Olo (NYSE:OLO) shares set a new 52-week low of $5.63. The stock traded down 0.44%.
    • Definitive Healthcare (NASDAQ:DH) stock set a new 52-week low of $8.07 on Friday, moving down 1.21%.
    • Tekla Healthcare (NYSE:HQH) stock set a new 52-week low of $15.96 on Friday, moving down 0.68%.
    • GDEV (NASDAQ:GDEV) stock achieved a new 52-week low on Friday morning, hitting $3.09 and moving down 9.33%.
    • Gogoro (NASDAQ:GGR) stock drifted down 0.55% on Friday morning to hit a new 52-week low of $2.67.
    • Silk Road Medical (NASDAQ:SILK) stock broke to a new 52-week low of $16.72 on Friday. Shares of the company traded down 1.52%.
    • DocGo (NASDAQ:DCGO) stock drifted down 5.11% on Friday morning to hit a new 52-week low of $5.76.
    • PIMCO Income Strategy (NYSE:PFN) stock broke to a new 52-week low of $6.63 on Friday. Shares of the company traded up 0.15%.
    • FuelCell Energy (NASDAQ:FCEL) stock broke to a new 52-week low of $1.23 on Friday. Shares of the company traded down 3.02%.
    • PIMCO Municipal Income (NYSE:PML) stock achieved a new 52-week low on Friday morning, hitting $8.28 and moving up 0.35%.
    • Nuveen California (NYSE:NKX) stock hit $10.71 on Friday morning, setting a new 52-week low for a change of down 0.28%.
    • Consensus Cloud Solutions (NASDAQ:CCSI) shares set a new yearly low of $25.05 this morning. The stock was down 2.26% on the session.
    • Theravance Biopharma (NASDAQ:TBPH) shares set a new yearly low of $9.05 this morning. The stock was down 5.77% on the session.
    • Lyell Immunopharma (NASDAQ:LYEL) stock set a new 52-week low of $1.66 on Friday, moving down 1.72%.
    • Perfect (NYSE:PERF) stock dropped to a yearly low on Friday of $3.21. Shares traded down 7.28%.
    • Seres Therapeutics (NASDAQ:MCRB) shares moved down 2.2% on Friday to hit a new 52-week low of $2.83, drifting down 2.2%.
    • Eaton Vance Municipal IT (NYSE:EVN) stock hit a yearly low of $9.26. The stock was up 0.22% for the day.
    • Butterfly Network (NYSE:BFLY) shares set a new yearly low of $1.61 this morning. The stock was up 8.57% on the session.
    • Aerovate Therapeutics (NASDAQ:AVTE) stock broke to a new 52-week low of $12.87 on Friday. Shares of the company traded down 5.14%.
    • Materialise (NASDAQ:MTLS) shares fell to $5.96 on Friday, setting a new 52-week low with a shift of down 1.32%.
    • QuantaSing Group (NASDAQ:QSG) shares were down 5.76% for the day, having made a 52-week low of $5.70.
    • TH International (NASDAQ:THCH) stock hit a yearly low of $1.93. The stock was down 2.99% for the day.
    • Expensify (NASDAQ:EXFY) stock set a new 52-week low of $3.56 on Friday, moving down 3.81%.
    • Nuvation Bio (NYSE:NUVB) shares were down 2.17% for the day, having made a 52-week low of $1.33.
    • SkyWater Technology (NASDAQ:SKYT) stock hit a yearly low of $6.06. The stock was down 1.77% for the day.
    • Nuveen Core Plus Impact (NYSE:NPCT) stock hit a new 52-week low of $9.51. The stock was down 0.15% on the session.
    • Citizens Financial Servs (NASDAQ:CZFS) stock broke to a new 52-week low of $49.69 on Friday. Shares of the company traded down 0.14%.
    • PIMCO Municipal Income (NYSE:PMF) shares hit a yearly low of $8.92. The stock was down 0.22% on the session.
    • Axogen (NASDAQ:AXGN) shares made a new 52-week low of $5.30 on Friday. The stock was down 2.44% for the day.
    • Fate Therapeutics (NASDAQ:FATE) shares set a new yearly low of $2.28 this morning. The stock was down 2.54% on the session.
    • Cambium Networks (NASDAQ:CMBM) shares made a new 52-week low of $7.43 on Friday. The stock was down 2.86% for the day.
    • Gossamer Bio (NASDAQ:GOSS) stock broke to a new 52-week low of $0.84 on Friday. Shares of the company traded down 1.68%.
    • eGain (NASDAQ:EGAN) shares set a new yearly low of $5.80 this morning. The stock was down 4.13% on the session.
    • Blackrock Investment (NYSE:BKN) shares hit a yearly low of $10.61. The stock was down 0.38% on the session.
    • SIGNA Sports United (NYSE:SSU) shares moved down 6.3% on Friday to hit a new 52-week low of $0.45, drifting down 6.3%.
    • PIMCO CA Muni Income Fund (NYSE:PCK) shares hit a yearly low of $5.44. The stock was down 0.7% on the session.
    • Prelude Therapeutics (NASDAQ:PRLD) stock drifted 0.0% (flat) on Friday morning to hit a new 52-week low of $3.07.
    • CoreCard (NYSE:CCRD) shares set a new yearly low of $20.01 this morning. The stock was down 0.74% on the session.
    • XIAO-I (NASDAQ:AIXI) shares fell to $2.17 on Friday, setting a new 52-week low with a shift of down 2.01%.
    • Gabelli Healthcare (NYSE:GRX) shares set a new yearly low of $9.10 this morning. The stock was down 0.22% on the session.
    • Skillz (NYSE:SKLZ) stock dropped to a yearly low on Friday of $6.32. Shares traded down 0.93%.
    • Zentek (NASDAQ:ZTEK) stock dropped to a yearly low on Friday of $1.19. Shares traded up 3.23%.
    • Lazydays Hldgs (NASDAQ:LAZY) shares set a new yearly low of $9.13 this morning. The stock was down 8.46% on the session.
    • Flaherty & Crumrine Prefd (NYSE:PFD) stock achieved a new 52-week low on Friday morning, hitting $9.41 and moving up 0.53%.
    • China Automotive Systems (NASDAQ:CAAS) stock drifted down 3.09% on Friday morning to hit a new 52-week low of $3.67.
    • NGM Biopharmaceuticals (NASDAQ:NGM) stock dropped to a yearly low on Friday of $1.29. Shares traded up 2.29%.
    • Honest Co (NASDAQ:HNST) stock hit $1.11 on Friday morning, setting a new 52-week low for a change of down 15.6%.
    • ContextLogic (NASDAQ:WISH) shares fell to $4.44 on Friday, setting a new 52-week low with a shift of down 1.74%.
    • Vacasa (NASDAQ:VCSA) stock broke to a new 52-week low of $0.40 on Friday. Shares of the company traded up 1.26%.
    • BioAtla (NASDAQ:BCAB) shares reached a new 52-week low of $2.03 on Friday morning, moving up 0.49%.
    • Sezzle (NASDAQ:SEZL) shares hit a yearly low of $14.01. The stock was down 7.2% on the session.
    • FibroGen (NASDAQ:FGEN) shares set a new yearly low of $0.88 this morning. The stock was down 2.54% on the session.
    • OFS Credit Co (NASDAQ:OCCI) shares made a new 52-week low of $7.26 on Friday. The stock was down 0.71% for the day.
    • GABELLI CONVERTIBLE (NYSE:GCV) shares made a new 52-week low of $3.73 on Friday. The stock was up 0.53% for the day.
    • Clene (NASDAQ:CLNN) shares made a new 52-week low of $0.56 on Friday. The stock was down 5.51% for the day.
    • Rani Therapeutics Hldgs (NASDAQ:RANI) shares fell to $2.80 on Friday, setting a new 52-week low with a shift of down 4.11%.
    • Spectral AI (NASDAQ:MDAI) shares were down 6.3% for the day, having made a 52-week low of $3.60.
    • Zapp Electric Vehicles (NASDAQ:ZAPP) stock hit a yearly low of $1.22. The stock was down 6.15% for the day.
    • Personalis (NASDAQ:PSNL) shares set a new 52-week low of $1.37. The stock traded down 0.77%.
    • Sol-Gel Technologies (NASDAQ:SLGL) stock set a new 52-week low of $2.16 on Friday, moving down 0.4%.
    • GEN Restaurant Gr (NASDAQ:GENK) shares made a new 52-week low of $12.59 on Friday. The stock was down 3.55% for the day.
    • Eargo (NASDAQ:EAR) stock hit a new 52-week low of $2.44. The stock was up 0.81% on the session.
    • Mira Pharmaceuticals (NASDAQ:MIRA) stock achieved a new 52-week low on Friday morning, hitting $3.41 and moving down 3.94%.
    • Brainstorm Cell (NASDAQ:BCLI) stock hit a yearly low of $0.95. The stock was down 5.0% for the day.
    • Lantern Pharma (NASDAQ:LTRN) shares set a new 52-week low of $4.00. The stock traded down 3.94%.
    • Prestige Wealth (NASDAQ:PWM) stock broke to a new 52-week low of $4.50 on Friday. Shares of the company traded down 4.88%.
    • Leap Therapeutics (NASDAQ:LPTX) stock hit a yearly low of $1.60. The stock was down 2.12% for the day.
    • Liberty TripAdvisor Hldgs (NASDAQ:LTRPA) shares were down 1.68% for the day, having made a 52-week low of $0.52.
    • Brilliant Earth Group (NASDAQ:BRLT) stock hit a yearly low of $3.07. The stock was down 2.82% for the day.
    • Enlivex Therapeutics (NASDAQ:ENLV) shares reached a new 52-week low of $1.72 on Friday morning, moving down 4.77%.
    • PIMCO New York Municipal (NYSE:PYN) stock achieved a new 52-week low on Friday morning, hitting $5.67 and moving up 0.18%.
    • Solowin Holdings (NASDAQ:SWIN) stock hit a new 52-week low of $2.27. The stock was down 10.04% on the session.
    • Koss (NASDAQ:KOSS) stock broke to a new 52-week low of $3.35 on Friday. Shares of the company traded down 2.31%.
    • RF Industries (NASDAQ:RFIL) shares hit a yearly low of $2.92. The stock was down 18.11% on the session.
    • SEALSQ (NASDAQ:LAES) shares fell to $3.05 on Friday, setting a new 52-week low with a shift of down 6.39%.
    • Sunworks (NASDAQ:SUNW) stock broke to a new 52-week low of $0.68 on Friday. Shares of the company traded down 3.48%.
    • IN8bio (NASDAQ:INAB) shares were down 0.53% for the day, having made a 52-week low of $0.90.
    • OncoCyte (NASDAQ:OCX) shares set a new 52-week low of $3.18. The stock traded up 2.13%.
    • Alpine 4 Holdings (NASDAQ:ALPP) stock set a new 52-week low of $0.91 on Friday, moving down 2.79%.
    • VBI Vaccines (NASDAQ:VBIV) stock set a new 52-week low of $1.01 on Friday, moving down 2.75%.
    • Protara Therapeutics (NASDAQ:TARA) shares set a new 52-week low of $2.05. The stock traded down 0.45%.
    • Cyngn (NASDAQ:CYN) shares made a new 52-week low of $0.50 on Friday. The stock was down 7.89% for the day.
    • Phoenix New Media (NYSE:FENG) shares reached a new 52-week low of $1.12 on Friday morning, moving down 0.83%.
    • Vaccinex (NASDAQ:VCNX) shares set a new 52-week low of $0.17. The stock traded down 8.97%.
    • EZGO Technologies (NASDAQ:EZGO) shares reached a new 52-week low of $0.16 on Friday morning, moving down 3.61%.
    • PolyPid (NASDAQ:PYPD) shares fell to $0.24 on Friday, setting a new 52-week low with a shift of down 7.49%.
    • Intrusion (NASDAQ:INTZ) stock achieved a new 52-week low on Friday morning, hitting $0.50 and moving down 4.61%.
    • Talis Biomedical (NASDAQ:TLIS) shares hit a yearly low of $5.79. The stock was down 4.99% on the session.
    • Remark Hldgs (NASDAQ:MARK) shares moved down 1.59% on Friday to hit a new 52-week low of $0.51, drifting down 1.59%.
    • Inhibikase Therapeutics (NASDAQ:IKT) stock broke to a new 52-week low of $1.65 on Friday. Shares of the company traded up 1.19%.
    • BioCardia (NASDAQ:BCDA) shares hit a yearly low of $0.39. The stock was down 0.28% on the session.
    • Addentax Group (NASDAQ:ATXG) stock hit a new 52-week low of $1.61. The stock was down 3.55% on the session.
    • Tempo Automation Holdings (NASDAQ:TMPO) stock dropped to a yearly low on Friday of $0.20. Shares traded down 2.86%.
    • ContraFect (NASDAQ:CFRX) stock hit a new 52-week low of $0.58. The stock was up 0.24% on the session.
    • Super League Enterprise (NASDAQ:SLE) shares set a new yearly low of $1.57 this morning. The stock was down 11.82% on the session.
    • Antelope Ent Hldgs (NASDAQ:AEHL) stock drifted down 6.12% on Friday morning to hit a new 52-week low of $0.30.
    • PaxMedica (NASDAQ:PXMD) shares set a new yearly low of $0.25 this morning. The stock was down 5.84% on the session.
    • ABVC BioPharma (NASDAQ:ABVC) stock hit a yearly low of $1.03. The stock was up 0.93% for the day.
    • Netcapital (NASDAQ:NCPL) stock broke to a new 52-week low of $0.42 on Friday. Shares of the company traded down 16.89%.
    • Siyata Mobile (NASDAQ:SYTA) shares reached a new 52-week low of $2.11 on Friday morning, moving down 3.77%.
    • Applied UV (NASDAQ:AUVI) shares set a new yearly low of $0.45 this morning. The stock was down 4.26% on the session.
    • Scinai Immunotherapeutics (NASDAQ:SCNI) shares fell to $0.95 on Friday, setting a new 52-week low with a shift of down 15.0%.
    • Baudax Bio (NASDAQ:BXRX) shares set a new 52-week low of $0.34. The stock traded down 2.53%.
    • RiceBran Tech (NASDAQ:RIBT) stock hit a yearly low of $0.45. The stock was down 7.16% for the day.
    • Allarity Therapeutics (NASDAQ:ALLR) shares were down 4.0% for the day, having made a 52-week low of $0.96.
    • Recruiter.Com Group (NASDAQ:RCRT) shares reached a new 52-week low of $1.42 on Friday morning, moving down 3.9%.
    • Blue Star Foods (NASDAQ:BSFC) stock set a new 52-week low of $0.35 on Friday, moving down 6.09%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $PLNT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PLNT
    $PLRX
    $PMF
    $PML

    CompanyDatePrice TargetRatingAnalyst
    Phreesia Inc.
    $PHR
    4/1/2026Mkt Outperform → Mkt Perform
    Citizens
    Phreesia Inc.
    $PHR
    3/31/2026$10.00Outperform → Neutral
    Robert W. Baird
    Phreesia Inc.
    $PHR
    3/31/2026$11.00Buy → Hold
    Truist
    Phreesia Inc.
    $PHR
    3/31/2026$10.00Buy → Neutral
    Citigroup
    Phreesia Inc.
    $PHR
    3/31/2026$16.00Overweight → Neutral
    Analyst
    Phreesia Inc.
    $PHR
    3/31/2026$35.00 → $14.00Buy
    Needham
    TKO Group Holdings Inc.
    $TKO
    3/30/2026$240.00Mkt Outperform
    Citizens
    CAVA Group Inc.
    $CAVA
    3/30/2026$91.00Neutral
    BNP Paribas Exane
    More analyst ratings

    $PLNT
    $PLRX
    $PMF
    $PML
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Macy's, Inc. to Participate in J.P. Morgan 12th Annual Retail Round Up

    Macy's, Inc. (NYSE:M) today announced that Tony Spring, chairman and chief executive officer, and Tom Edwards, chief operating officer and chief financial officer, will participate in the J.P. Morgan 12th Annual Retail Round Up on Wednesday, April 8, 2026. About Macy's, Inc. Macy's, Inc. (NYSE:M) is a trusted source for quality brands through our iconic nameplates – Macy's, Bloomingdale's and Bluemercury. Headquartered in New York City, our comprehensive digital and nationwide footprint empowers us to deliver a seamless shopping experience for our customers. For more information, visit macysinc.com. View source version on businesswire.com: https://www.businesswire.com/news/home/2026040

    4/1/26 8:30:00 AM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    SEALSQ and Kaynes Semicon Mark a Major Milestone in the Development of India's First Post-Quantum Cryptography Personalization Center with the Inauguration of Kaynes' New OSAT Facility in Sanand, Gujarat

    Geneva, Switzerland / Sanand, Gujarat, India, April 01, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ:LAES) ("SEALSQ" or "Company"), a leader in semiconductor, PKI, and post-quantum technology solutions today announced its participation at the inauguration of Kaynes Semicon's state-of-the-art Outsourced Semiconductor Assembly and Test (OSAT) facility in Sanand, Gujarat, and within it, the first phase localization of the planned SEALSQ–Kaynes Post-Quantum Cryptography (PQC) Personalization Center (‘the Center"), which will be India's first facility dedicated to the sovereign, large-scale personalization of quantum-safe semiconductor devices. The inauguration was attended by Prime Ministe

    4/1/26 8:30:00 AM ET
    $LAES
    Semiconductors
    Technology

    Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib from Daiichi Sankyo

    With acquisition of Japan rights, Nuvation Bio now has global development and commercialization rights for safusidenibAgreement provides Nuvation Bio ownership of global clinical development program, inclusive of clinical trials, past and current data generation, and future publicationsNEW YORK, April 1, 2026 /PRNewswire/ -- Nuvation Bio Inc. (NYSE:NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced the company has amended its existing exclusive license agreement for safusidenib with Daiichi Sankyo (TSE :4568) to include Japan rights, effectively securing exclusive global development and commercialization rights of the inv

    4/1/26 8:00:00 AM ET
    $NUVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Buonanno Franck Jean

    4 - SEALSQ Corp (0001951222) (Issuer)

    4/1/26 8:30:05 AM ET
    $LAES
    Semiconductors
    Technology

    SEC Form 3 filed by new insider Phillips Margain Carlos

    3 - GRUPO TELEVISA, S.A.B. (0000912892) (Issuer)

    3/31/26 8:15:57 PM ET
    $TV
    Broadcasting
    Industrials

    SEC Form 3 filed by new insider Mejia Barberena Sebastian

    3 - GRUPO TELEVISA, S.A.B. (0000912892) (Issuer)

    3/31/26 8:14:13 PM ET
    $TV
    Broadcasting
    Industrials

    $PLNT
    $PLRX
    $PMF
    $PML
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Phreesia downgraded by Citizens

    Citizens downgraded Phreesia from Mkt Outperform to Mkt Perform

    4/1/26 8:19:23 AM ET
    $PHR
    Real Estate

    Phreesia downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded Phreesia from Outperform to Neutral and set a new price target of $10.00

    3/31/26 8:08:36 AM ET
    $PHR
    Real Estate

    Phreesia downgraded by Truist with a new price target

    Truist downgraded Phreesia from Buy to Hold and set a new price target of $11.00

    3/31/26 8:07:55 AM ET
    $PHR
    Real Estate

    $PLNT
    $PLRX
    $PMF
    $PML
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Bank Of America Corp /De/ bought $503 worth of shares (65 units at $7.74) and sold $496 worth of shares (65 units at $7.63) (SEC Form 4)

    4 - PIMCO MUNICIPAL INCOME FUND II (0001170299) (Issuer)

    3/17/26 12:18:34 PM ET
    $PML
    Investment Managers
    Finance

    Large owner Arch Venture Partners Ix, Llc bought $12,499,985 worth of shares (488,090 units at $25.61) (SEC Form 4)

    4 - Lyell Immunopharma, Inc. (0001806952) (Issuer)

    3/9/26 4:36:20 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Arch Venture Fund Xiii, L.P. bought $12,499,985 worth of shares (488,090 units at $25.61) (SEC Form 4)

    4 - Lyell Immunopharma, Inc. (0001806952) (Issuer)

    3/9/26 4:34:54 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for REVUFORJ issued to SYNDAX PHARMACEUTICALS INC

    Submission status for SYNDAX PHARMACEUTICALS INC's drug REVUFORJ (ORIG-1) with active ingredient REVUMENIB has changed to 'Approval' on 11/15/2024. Application Category: NDA, Application Number: 218944, Application Classification: Type 1 - New Molecular Entity

    11/18/24 9:22:42 AM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    September 26, 2024 - FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia

    For Immediate Release: September 26, 2024 Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.   “Schizophrenia is a leading

    9/26/24 6:42:20 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    SEC Filings

    View All

    SEC Form 6-K filed by XIAO-I Corporation

    6-K - Xiao-I Corp (0001935172) (Filer)

    4/1/26 10:45:07 AM ET
    $AIXI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 6-K filed by Zentek Ltd.

    6-K - Zentek Ltd. (0001904501) (Filer)

    4/1/26 10:08:37 AM ET
    $ZTEK
    Major Chemicals
    Industrials

    Allarity Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Allarity Therapeutics, Inc. (0001860657) (Filer)

    4/1/26 8:54:39 AM ET
    $ALLR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Leadership Updates

    Live Leadership Updates

    View All

    Insulet Appoints Mike Panos as Chief Commercial Officer

    Insulet Corporation (NASDAQ:PODD) ("Insulet" or the "Company"), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the appointment of Mike Panos as Executive Vice President, Chief Commercial Officer, effective immediately. In this role, Mr. Panos will lead Insulet's global commercial organization, reporting to President and Chief Executive Officer Ashley McEvoy. He will also be a member of the Executive Leadership Team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330524787/en/ "We have a significant growth opportunity in front of us, driven by strong clinical outcomes

    3/30/26 8:30:00 AM ET
    $PODD
    Medical/Dental Instruments
    Health Care

    Galapagos Announces Nomination of Gino Santini to its Board of Directors

    Subject to his election by shareholders, the Board intends to appoint Mr. Santini as Chair, succeeding Jérôme Contamine  Mr. Santini will bring extensive corporate governance, business development and industry leadership experience to the Board Mechelen, Belgium; March 26, 2026, 21:02 CET — Galapagos NV ((Euronext &, NASDAQ:GLPG), today announced the proposed appointment of Gino Santini as a Non-Executive Independent Director, with the intention to appoint him as Chair of its Board of Directors, subject to shareholder approval at the Annual Shareholders' Meeting (AGM) on April 28, 2026. If elected, Gino Santini will replace current Director and Chair Jérôme Contamine, whose mandate as a m

    3/26/26 4:02:00 PM ET
    $GLPG
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders' Meetings

    Mechelen, Belgium; March 26, 2026, 21:01 CET; regulated information — Galapagos NV ((Euronext &, NASDAQ:GLPG) today published its annual report for the financial year 2025 and announced that its Annual Shareholders' Meeting (AGM) and an Extraordinary Shareholders' Meeting (EGM) will be held sequentially on Tuesday, April 28, 2026 at 14:00 CET and 15:00 CET at Schaliënhoevedreef 20T, 2800 Mechelen, Belgium. The annual report for the financial year 2025, including a review of figures and performance, is available online at https://www.glpg.com/financial-reports and can also be downloaded as PDF. The annual 2025 Form 20-F filing with the SEC is available at www.sec.gov/edgar. Galapagos has t

    3/26/26 4:01:00 PM ET
    $GLPG
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Protara Therapeutics Inc.

    SC 13G - Protara Therapeutics, Inc. (0001359931) (Subject)

    12/17/24 4:02:03 PM ET
    $TARA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Nuveen Core Plus Impact Fund

    SC 13D/A - Nuveen Core Plus Impact Fund (0001835068) (Subject)

    12/16/24 6:56:51 PM ET
    $NPCT
    Investment Managers
    Finance

    SEC Form SC 13D filed by Prestige Wealth Inc.

    SC 13D - Prestige Wealth Inc. (0001765850) (Subject)

    12/13/24 5:00:03 PM ET
    $PWM
    Finance: Consumer Services
    Finance

    $PLNT
    $PLRX
    $PMF
    $PML
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Led to the Purchase at Aerovate Therapeutics Inc. on Jun 20?

    Recently, on June 20, 2024, a notable insider purchase was made at Aerovate Therapeutics Inc. Director Ra Capital Management, L.P. bought $1,549,944 worth of shares, acquiring 928,110 units at $1.67 per share as reported in the SEC Form 4. Insider transactions like these are closely watched by investors as they can provide valuable insights into the company's prospects. When analyzing insider transactions, it is essential to look for patterns and trends among multiple transactions to gauge the overall sentiment within the company. Several other SEC Form 4 filings were made around the same time, on June 7, 2024, by various insiders at Aerovate Therapeutics Inc. These included transactions by

    6/21/24 3:23:59 PM ET
    $AVTE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Financials

    Live finance-specific insights

    View All

    Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration

    JERUSALEM, April 1, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI); ("Scinai" or the "Company"), a biopharmaceutical company operating a dual R&D and CDMO business model designed to combine therapeutic innovation with revenue-generating drug development and manufacturing services, today reported financial results for the year ended December 31, 2025. Corporate and Financial HighlightsCDMO revenues doubled year-over-year to $1.3 million, reflecting continued commercial traction and execution of development and manufacturing programsExpanded CDMO platform post year-end through the acquisition of Recipharm Israel and entry into a strategic commercial collaboration with Reciph

    4/1/26 7:35:00 AM ET
    $SCNI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026

    Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it will report financial results for the first quarter of 2026 on Wednesday, May 6, 2026, before the opening of the financial markets. In connection with the release, management will host a conference call that day at 8:00 a.m. (Eastern Time). The link to the live call will be available on the Investor Relations section of the Company's website at investors.insulet.com, "Events and Presentations," and will be archived for future replay. You may also access the live call by dialing (888) 770-7129 for domestic callers, or (929

    4/1/26 7:00:00 AM ET
    $PODD
    Medical/Dental Instruments
    Health Care

    Skillz Reports 2025 Fourth Quarter and Full Year 2025 Results

    Skillz Inc. (NYSE:SKLZ) ("Skillz" or the "Company"), the leading mobile games platform bringing fair competition to players worldwide, today reported financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights: Revenue of $30.0 million Gross profit of $26.5 million Net loss of $17.9 million Adjusted EBITDA1 loss of $10.0 million Paying monthly active users (PMAUs)2 of 141 thousand Average revenue per PMAU (ARPPU)3 of $71.1 Total operating expenses (which does not include cost of revenue) of $42.7 million Full Year 2025 Financial Highlights: Revenue of $104.5 million Gross profit of $91.4 million

    3/31/26 4:39:00 PM ET
    $SKLZ
    EDP Services
    Technology